Cherishing the Simple Things
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random and not inherited by her children.
Musician and producer Tom Bajoras has focused on the sorrow, joy, and beauty of life as he fights PNET with standard and new treatments.
Julie Sutcliffe is working with targeted radionuclide therapy to go after pancreatic cancer cells that have spread beyond the pancreas.
Andy Spiteri is a fantasy sports enthusiast, so he turned to his favorite activity to help him through pancreatic cancer treatment.
Steven Lewis has faced down pancreatic cancer twice–first with a Whipple, CyberKnife, and chemoradiation; then with liver surgery for metastasis.
Physician and researcher Douglas Fearon and his lab have a possible explanation for how cancer cells metastasize, and the role surgery may play in this process.
The Foundation’s dedicated lab at Cold Spring Harbor Laboratory (CSHL) used organoid technology to find that pancreatic cancer cells reprogram gene enhancers to achieve the ability to spread. The research, appearing online on August 8, 2017, in Cell, provides strong evidence supporting this explanation of metastasis, which is the cause of most cancer deaths. Experiments…
When Dr. Steve Bigelsen was diagnosed with stage IV pancreatic cancer, chemosensitivity testing led him to treatments beyond standard of care.